Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Theriogenology ; 86(5): 1222-30, 2016 Sep 15.
Article in English | MEDLINE | ID: mdl-27180328

ABSTRACT

Cryopreservation of in vitro produced bovine embryos is associated with significantly reduced survival rates, mainly due to insufficient quality of the embryos. Caffeine supplementation during IVM has been used to delay meiotic resumption and concomitantly also increased embryo quality. Here, we investigated the influence of pre-IVM with caffeine on oocyte maturation, intraoocyte cAMP concentration, developmental competence after IVF, and blastocyst cryotolerance. Oocytes were obtained by slicing of ovaries and were submitted to either 2 hours culture before IVM with or without caffeine (0, 1, 5, 10, 20, 30 mM), or standard IVM (no pre-IVM). Oocytes were in vitro matured and fertilized and zygotes were cultured under standard in vitro conditions until Day 8. Expanded blastocysts derived from either standard control or the 10-mM caffeine treatments were submitted to vitrification. Caffeine delayed meiotic resumption after 9-hour IVM in a concentration-dependent manner. The cAMP levels were similar before and after IVM. Matured oocytes, cleavage, and blastocyst rates were reduced in the 30-mM caffeine concentration and were similar among the other treatment groups. Number and proportion of inner cell mass and trophectoderm cells in blastocysts did not differ among treatments. Forty-eight hours after thawing, hatching rates were higher in the 10-mM caffeine group (73.8%) compared with the standard control (59.7%). Reexpansion rates and total number of cells after 48 hours were similar in both treatments. The ratio of live/total cells was higher in the caffeine treatment. These results suggest that caffeine supplementation before IVM delayed meiotic resumption and improved blastocyst quality shown in higher cryotolerance.


Subject(s)
Caffeine/pharmacology , Cattle , Cryopreservation/veterinary , Embryo Culture Techniques/veterinary , In Vitro Oocyte Maturation Techniques/veterinary , Oocytes/drug effects , Animals , Blastocyst/cytology , Blastocyst/drug effects , Female , Phosphodiesterase Inhibitors/pharmacology , Vitrification
2.
Epigenetics ; 9(6): 803-15, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24709985

ABSTRACT

The use of Assisted Reproductive Technologies (ARTs) in modern cattle breeding is an important tool for improving the production of dairy and beef cattle. A frequently employed ART in the cattle industry is in vitro production of embryos. However, bovine in vitro produced embryos differ greatly from their in vivo produced counterparts in many facets, including developmental competence. The lower developmental capacity of these embryos could be due to the stress to which the gametes and/or embryos are exposed during in vitro embryo production, specifically ovarian hormonal stimulation, follicular aspiration, oocyte in vitro maturation in hormone supplemented medium, sperm handling, gamete cryopreservation, and culture of embryos. The negative effects of some ARTs on embryo development could, at least partially, be explained by disruption of the physiological epigenetic profile of the gametes and/or embryos. Here, we review the current literature with regard to the putative link between ARTs used in bovine reproduction and epigenetic disorders and changes in the expression profile of embryonic genes. Information on the relationship between reproductive biotechnologies and epigenetic disorders and aberrant gene expression in bovine embryos is limited and novel approaches are needed to explore ways in which ARTs can be improved to avoid epigenetic disorders.


Subject(s)
Cattle Diseases/genetics , Cattle , Embryonic Development/genetics , Epigenesis, Genetic , Gene Expression , Reproductive Techniques, Assisted/veterinary , Animals , Embryo Culture Techniques , Humans , Male , Nuclear Transfer Techniques/adverse effects , Nuclear Transfer Techniques/veterinary , Oocytes/transplantation , Reproductive Techniques, Assisted/adverse effects , Specimen Handling/veterinary , Spermatozoa/transplantation , Superovulation/genetics
SELECTION OF CITATIONS
SEARCH DETAIL